Menu
Subscribe to our Email Alerts
About Us
Island at a glance
Board
Key Management
Scientific Advisory Board
Collaborations
Science
About ISLA-101
Scientific Publications
Drug repurposing and benefits
Disease and drug terms explained
Investor Centre
Investor Welcome
Clinical programme
ASX Announcements
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
Media
News
Presentations
Contact
Contact Us
Subscribe for Email Alerts
Investor Centre
Investor Centre
>
ASX Announcements
Investor Welcome
Clinical programme
ASX Announcements
Financial Reports
Share Price Information
Shareholder Services
Investor Fact Sheet
Corporate Governance
Corporate Directory
International Investors
Research Coverage
AGM
ASX Announcements
Filter by Year:
2023
2022
2021
28-Dec-2022
ILA submits IND to US FDA for Phase 2a PEACH clinical trial
19-Dec-2022
Notice of Change of Auditor
15-Dec-2022
Island online investor briefing presentation
15-Dec-2022
IRB approval received for ISLA101 Phase 2a clinical trial
15-Dec-2022
ISLA101 drug product achieves stability milestone
12-Dec-2022
Island investor briefing invitation
5-Dec-2022
ISLA-101 trial update and investor presentation
29-Nov-2022
Island to present at World Antiviral Congress 2022
21-Nov-2022
Change in substantial holding
17-Nov-2022
Results of AGM
1
2
3
4
5
Next
.png){kind=logo}
